CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 15 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 25,000 | $36,000 | 0.01% |
| Virtu Financial LLC | 29,033 | $41,000 | 0.00% |
| BREWIN DOLPHIN LTD | 5,586 | $7,932 | 0.00% |
| SIGNET FINANCIAL MANAGEMENT, LLC | 23 | $0 | 0.00% |
| UBS Group AG | 10,380 | $14,000 | 0.00% |
| D'Orazio & Associates, Inc. | 100 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 12,240 | $17,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 83 | $0 | 0.00% |
| NORTHERN TRUST CORP | 13,399 | $19,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 21,692 | $30,000 | 0.00% |